Pancreatic Cancer Research

ResearcherShandong UniversityActive in the last 2 years

Ronghua Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5925-350X; OpenAlex author ID A5100739603. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 4 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 9

  1. Pancreatic cancer cells escape T/NK cell immune surveillance through the expressional separation of CD58. Co-author DOI 10.1136/jitc-2025-012163↗
  2. Pancreatic cancer cell-derived migrasomes promote cancer progression by fostering an immunosuppressive tumor microenvironment. Co-author DOI 10.1016/j.canlet.2024.217289↗
  3. Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations. First author DOI 10.1007/s00262-020-02816-0↗
  4. Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor microenvironment. Co-author DOI 10.1007/s00262-020-02542-7↗
  5. Surgery for synchronous and metachronous single-organ metastasis of pancreatic cancer: a SEER database analysis and systematic literature review. First author DOI 10.1038/s41598-020-61487-0↗
  6. Identification of prognosis-related genes and construction of multi-regulatory networks in pancreatic cancer microenvironment by bioinformatics analysis. Co-author DOI 10.1186/s12935-020-01426-1↗
  7. CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration. Co-author DOI 10.7150/jca.40517↗
  8. Pancreatic cancer-educated macrophages protect cancer cells from complement-dependent cytotoxicity by up-regulation of CD59. Co-author DOI 10.1038/s41419-019-2065-4↗
  9. Tumor size classification of the 8th edition of TNM staging system is superior to that of the 7th edition in predicting the survival outcome of pancreatic canc… Co-author DOI 10.1038/s41598-018-28193-4↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qiaofei Liu · 6 shared papers, 2019–2025 · strength 0.92
  2. Quan Liao · 7 shared papers, 2018–2025 · strength 0.88
  3. Jorg H. Kleeff · 4 shared papers, 2020–2025 · strength 0.65
  4. Tong Li · 5 shared papers, 2020–2024 · strength 0.63
  5. Ming Cui · 5 shared papers, 2018–2024 · strength 0.56
  6. Yalu Zhang · 3 shared papers, 2021–2025 · strength 0.55
  7. Sen Yang · 3 shared papers, 2021–2025 · strength 0.55
  8. Yupei Zhao · 5 shared papers, 2018–2020 · strength 0.52
  9. Junya Peng · 3 shared papers, 2019–2024 · strength 0.39
  10. Xiang Zhang · 4 shared papers, 2018–2021 · strength 0.38
  11. Junyi Gao · 3 shared papers, 2020–2024 · strength 0.38
  12. Quan Liao · 2 shared papers, 2020–2024 · strength 0.32
  13. Jingkai Liu · 3 shared papers, 2020–2021 · strength 0.31
  14. Qiaofei Liu · 3 shared papers, 2018–2021 · strength 0.28
  15. Huaijin Zheng · 1 shared paper, 2025 · strength 0.26
  16. Mengyi Wang · 2 shared papers, 2019–2020 · strength 0.21
  17. Huanwen Wu · 2 shared papers, 2020–2021 · strength 0.20
  18. Menghua Dai · 2 shared papers, 2018–2020 · strength 0.16
  19. Taiping Zhang · 2 shared papers, 2018–2020 · strength 0.16
  20. Junchao Guo · 2 shared papers, 2018–2020 · strength 0.16
  21. Christoph W. Michalski · 1 shared paper, 2020 · strength 0.13
  22. Li Zhou · 1 shared paper, 2020 · strength 0.09
  23. Boju Pan · 1 shared paper, 2020 · strength 0.09
  24. Weibin Wang · 1 shared paper, 2020 · strength 0.09
  25. Wenming Wu · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.